Restraining Medicine Prices: Controls vs. Competition

Authors

Murray L. Weidenbaum, Washington University in St Louis

Files

Publication Date

4-1-1993

Series Information

Policy Study 116

Publisher

Center for the Study of American Business (CSAB), Washington University in St. Louis, St. Louis, MO 63130

Description

With the cost of prescription medicines constantly rising, the government has been considering price controls. This report explains the R&D process from laboratory studies to FDA review to approval by the FDA. As an alternative to price controls, competition could be a way for helping to keep prices down.

Keywords

Pharmaceutical Industry, Food and Drug Administration, Price Controls, Research and Development

Disciplines

Economics | Public Policy

Comments

The Center for the Study of American Business (CSAB), 1975-2001, is the predecessor of the Weidenbaum Center on the Economy, Government, and Public Policy at Washington University in St. Louis. Permanent URL: http://dx.doi/org/10.7936/K7K935Q7

DOI

doi:10.7936/K7K935Q7

Recommended Citation

Weidenbaum, Murray L., "Restraining Medicine Prices: Controls vs. Competition", Policy Study 116, 1993, doi:10.7936/K7K935Q7.
Murray Weidenbaum Publications, https://openscholarship.wustl.edu/mlw_papers/163.